FEATURED NEWS

A number of private organisations in the media, medical professionals, and Pfizer have claimed the Comirnaty (Pfizer) COVID-19 vaccine was safe and effective without outlining the risks or lack of quality assurance in regard to testing the vaccine. Genotoxicity, carcinogenic, and longitudinal testing are just some of the tests that didn’t occur. Other risks with missing information are outlined in the table below. There were only around 19,000 from the vaccinated group evaluated when over 21,000 were vaccinated. One of these was Maddie De Garay, a 12-year-old girl, who ended up in a wheelchair being fed through a tube. 1. What laws are in place to ensure that all risks are outlined, as well as the rewards, when medical products are advertised or promoted – if laws do exist why weren’t they upheld in the case the Comirnaty (Pfizer) COVID-19 vaccine? 2. What recourse do victims of the Comirnaty (Pfizer) COVID-19 vaccine have against private organisations such as the media, pharmaceutical companies, and health professionals who constantly repeated the vaccine is safe and effective without highlighting the risks? 3. What steps can the Australian Competition and Consumer Commission take in regard to the promotion of medical products in order to prevent misleading and deceptive conduct in the future? (See table)

Question Number: 70
PDR Number: SBE070
Date Submitted: 16/11/2022
Department or Body: Australian Competition and Consumer Commission

1. This question relates to matters that are regulated by the Therapeutic Goods Administration (TGA), which is responsible for regulating the supply, import, export, manufacturing and advertising of therapeutic goods, medical devices and medicines.

2. This question should be directed to the TGA.

3. While the ACCC may take action under the Australian Consumer Law for conduct in trade or commerce which it considers is capable of reaching the legal threshold of being misleading and deceptive or likely to mislead or deceive, it generally does not become involved in matters that are within the remit of industry specific regulators that have the regulatory focus and expertise to better deal with the conduct. However, the ACCC does engage closely with such regulators, which includes the TGA, to share information and intelligence on related issues.

Share:

Facebook
Twitter
Pinterest
LinkedIn

SENATE SPEECHES

THE ISSUES

Click on an interest area to read articles and learn more about the work I am doing in Parliament.

Taxation, Finance & Economy

READ MORE

Education & Family

READ MORE

Energy

READ MORE

Environment

READ MORE

Health, Aged Care & Seniors

READ MORE

Primary Industries

READ MORE

Immigration & Foreign Affairs

READ MORE

Infrastructure, Manufacturing, Transport & Tourism

READ MORE

Defence

READ MORE

Federation Reform

READ MORE

I may get kicked off social media soon for speaking too much truth so please join my mailing list so we can always stay in touch...

Thank you,

Gerard